English
  1. Home
  2. Stocks
  3. Neulandlab Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Neuland Laboratories Share Price Neuland Laboratories

    Mid Cap
    ₹7,139.7
    -7.15 (-0.1%)
    13 May, 2024 00:26 BSE: 524558 NSE: NEULANDLABISIN: INE794A01010

    Start SIP in Neuland Laboratories

    Start SIP

    Neuland Laboratories Performance

    Day Range

    • Low 7,001
    • High 7,300
    ₹ 7,139

    52 Week Range

    • Low 2,082
    • High 7,790
    ₹ 7,139
    • Open Price7,159
    • Previous Close7,147
    • Volume23407

    Neuland Laboratories Share Price

    • Over 1 Month +15.33%
    • Over 3 Month +5.46%
    • Over 6 Month +32.93%
    • Over 1 Year +181.28%

    Neuland Laboratories Key Statistics

    P/E Ratio 30.5
    PEG Ratio 0.4
    Market Cap Cr 9,160
    Price to Book Ratio 7.1
    EPS 127.7
    Dividend 0.1
    Relative Strength Index 50.94
    Money Flow Index 39.25
    MACD Signal 226.41
    Average True Range 326.91
    Neuland Laboratories Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 385393418363407
    Operating Expenses Qtr Cr 278272280266287
    Operating Profit Qtr Cr 10712113797120
    Depreciation Qtr Cr 1615151413
    Interest Qtr Cr 44424
    Tax Qtr Cr 2423322126
    Net Profit Qtr Cr 6881896285
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,5711,201
    Operating Expenses Annual Cr 1,097920
    Operating Profit Annual in Cr 462271
    Depreciation Cr 6053
    Interest Annual Cr 1413
    Tax Annual Cr 10152
    Net Profit Annual Cr 300163
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 260239
    Cash from Investing Activity Annual Cr -150-61
    Cash from Financing Annual Activity Cr -69-136
    Net Cash Flow Annual Cr 41
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,277988
    Fixed Assets Annual Cr 870798
    Total Non Current Assets Annual Cr 911819
    Total Current Assets Annual Cr 919760
    Total Assets Annual Cr 1,8311,579
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 990766
    ROE Annual % 2317
    ROCE Annual % 3020
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3024
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 385393418363407
    Operating Expenses Qtr Cr 278272280266287
    Operating Profit Qtr Cr 10712113797120
    Depreciation Qtr Cr 1615151413
    Interest Qtr Cr 44424
    Tax Qtr Cr 2523322126
    Net Profit Qtr Cr 6881896285
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,5711,201
    Operating Expenses Annual Cr 1,096919
    Operating Profit Annual in Cr 463272
    Depreciation Cr 6053
    Interest Annual Cr 1413
    Tax Annual Cr 10152
    Net Profit Annual Cr 300164
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 261237
    Cash from Investing Activity Annual Cr -150-61
    Cash from Financing Annual Activity Cr -69-136
    Net Cash Flow Annual Cr 40
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,283994
    Fixed Assets Annual Cr 590519
    Total Non Current Assets Annual Cr 911819
    Total Current Assets Annual Cr 921761
    Total Assets Annual Cr 1,8331,580
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 994771
    ROE Annual % 2316
    ROCE Annual % 3020
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3024
    Sign Up to Know More
    Invest in Neuland Laboratories

    Neuland Laboratories Technicals

    EMA & SMA

    Current Price
    ₹7,139.7
    -7.15 (-0.1%)
    pointer
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹7,188.72
    • 50 Day
    • ₹6,845.66
    • 100 Day
    • ₹6,333.47
    • 200 Day
    • ₹5,412.28
    • 20 Day
    • ₹7,277.58
    • 50 Day
    • ₹6,779.80
    • 100 Day
    • ₹6,362.00
    • 200 Day
    • ₹5,251.36

    Neuland Laboratories Resistance and Support

    PIVOT
    ₹7,146.9
    Resistance
    First Resistance 7,292.80
    Second Resistance 7,445.90
    Third Resistance 7,591.80
    RSI 50.94
    MFI 39.25
    MACD Single Line 226.41
    MACD 180.01
    Support
    First Resistance 6,993.80
    Second Resistance 6,847.90
    Third Resistance 6,694.80

    Neuland Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 24,379 1,300,132 53.33
    Week 19,881 1,122,061 56.44
    1 Month 41,877 2,087,985 49.86
    6 Month 51,547 3,174,246 61.58

    Neuland Laboratories Result Highlights

    Neuland Laboratories Synopsis

    NSE-Medical-Diversified

    Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1191.20 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2023. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.
    Market Cap 9,160
    Sales 1,559
    Shares in Float 0.86
    No of funds 175
    Yield 0.14
    Book Value 7.22
    U/D Vol ratio 1.2
    LTDebt / Equity 4
    Alpha 0.41
    Beta 0.98

    Neuland Laboratories

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 32.74%32.8%35.97%36.03%
    Mutual Funds 3.88%1.83%1.94%1.57%
    Foreign Portfolio Investors 24.43%22.69%21.57%20.19%
    Individual Investors 27.97%29.52%27.86%29.01%
    Others 10.98%13.16%12.66%13.2%

    Neuland Laboratories Management

    Name Designation
    Dr. Davuluri Rama Mohan Rao Executive Chairman
    Mr. Davuluri Sucheth Rao Vice Chairman & CEO
    Mr. Davuluri Saharsh Rao Vice Chairman & Mng.Director
    Dr. Christopher M Cimarusti Non Executive Director
    Mr. Humayun Dhanrajgir Ind. Non-Executive Director
    Mrs. Bharati Rao Ind. Non-Executive Director
    Dr. Nirmala Murthy Ind. Non-Executive Director
    Mr. Parampally Vasudeva Maiya Ind. Non-Executive Director
    Mr. Homi Rustum Khusrokhan Ind. Non-Executive Director
    Mr. Prasad Raghava Menon Ind. Non-Executive Director

    Neuland Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Neuland Laboratories Corporate Action

    Date Purpose Remarks
    2024-05-10 Audited Results & Final Dividend
    2024-02-08 Quarterly Results
    2023-11-07 Quarterly Results
    2023-08-03 Quarterly Results
    2023-05-11 Audited Results & Final Dividend
    Date Purpose Remarks
    2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend

    Neuland Laboratories MF Shareholding

    Name Amount(cr)
    HSBC Small Cap Fund Fund Regular Growth 13,401
    Bandhan Small Cap Fund Regular Growth 4,385
    WhiteOak Capital Flexi Cap Fund Regular Growth 3,237
    HSBC Multi Cap Fund Regular Growth 2,670
    Bajaj Finserv Flexi Cap Fund Regular Growth 2,439

    Neuland Laboratories FAQs

    What is Share Price of Neuland Laboratories ?

    Neuland Laboratories share price is ₹7,139 As on 13 May, 2024 | 00:12

    What is the Market Cap of Neuland Laboratories ?

    The Market Cap of Neuland Laboratories is ₹9160.2 Cr As on 13 May, 2024 | 00:12

    What is the P/E ratio of Neuland Laboratories ?

    The P/E ratio of Neuland Laboratories is 30.5 As on 13 May, 2024 | 00:12

    What is the PB ratio of Neuland Laboratories ?

    The PB ratio of Neuland Laboratories is 7.1 As on 13 May, 2024 | 00:12

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.